𝔖 Bobbio Scriptorium
✦   LIBER   ✦

DNA cytosine methylation in brain of patients with Alzheimer's disease

✍ Scribed by Netanel G. Schwob; Josephine Nalbantoglu; Kenneth E. M. Hastings; Tom Mikkelsen; Dr Neil R. Cashman


Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
399 KB
Volume
28
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

We developed a novel quantitative assay to test the hypothesis that defects in DNA cytosine methylation might be responsible for the brain chromatin abnormalities and transcriptional alterations observed in patients with Alzheimer's disease (AD). We found no significant difference in percent methylation of CCGG sites from brain DNA of 44 patients with AD compared with 20 normal subjects. These results, however, would not exclude genomic redistribution of methylcytosine in AD, or disturbed methylation of a limited population of critical brain‐specific genes.


πŸ“œ SIMILAR VOLUMES


Psychometric behaviour of BDI in Alzheim
✍ A. C. Wagle; L. W. Ho; S. A. Wagle; G. E. Berrios πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 97 KB πŸ‘ 2 views

The psychometric properties of the Beck Depression Inventory (BDI) in subjects with Alzheimer's disease (AD) and depression have not been fully evaluated. Item endorsement patterns may be distorted by the presence of AD. This was tested by applying the BDI to a sample of 129 subjects with probable A

Increased hair polyamine levels in patie
✍ Man Ho Choi; Kyoung-Rae Kim; In Seong Kim; Dong Seok Lho; Bong Chul Chung πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 108 KB πŸ‘ 1 views

Recently, the neurotoxic amyloid ␀-peptide was shown to up-regulate polyamine metabolism by increasing ornithine decarboxylase (ODC) activity and polyamine uptake by initiating free radical damage in Alzheimer's disease (AD). 1 Because of these findings, polyamines have been considered to play an im